Embedded Files
†Equally contributed; *Corresponding
Thrombolysis, cellular ablation, and drug delivery using an ionic liquid in venous tumor thrombus.
H. Keum† , J. Kim† , Z. Zhang, H. Albadawi, R. Oklu* (In preparation)
Intraosseous delivery of an ionic liquid-based thermoresponsive hydrogel for the treatment of osteomyelitis.
H. Keum† , J. Kim† , H. Albadawi, E. Graf, N. Callisen, R. Oklu* (In revision)
J. Kim, H. Keum, H. Albadawi, I. Altinbasak, F. Yavuz, E. Graf, N. Mishra, R. Oklu*
Adv. Mater. 37(29):2503179 (2025) (IF: 26.8, Materials Science, multidisciplinary 2.1%)
J. Kim, Z. Zhang, H. Albadawi, H. Keum, J. L. Mayer, E. Graf, R. Oklu*
Adv. Sci. (Inside front cover) 12(20): 2414642 (2025) (IF: 14.1, Materials Science, multidisciplinary 7.1%)
J. Kim, H. Keum, H. Albadawi, Z. Zhang, E. Graf, E. Cevik, R. Oklu*
Adv. Mater. (Inside front cover) 36(46): 2405805 (2024) (IF: 27.4, Materials Science, multidisciplinary 2.4%)
A human skin-on-a-chip platform for microneedling-driven skin cancer treatment.
N. R. Barros, R. Kang, J. Kim, M. Ermis, H. J. Kim, M. R. Dokmeci, J. Lee*
Mater. Today Bio 30: 101399 (2024) (IF: 8.7, Engineering, biomedical 8.5%)
Biocompatible Liquid Embolic for the Treatment of Microvascular Hemorrhage.
H. Keum, J. Kim, Z. Zhang, E. Graf, H. Albadawi, R. Oklu*
Adv. Sci. 11(34): 2403615 (2024) (IF: 14.3, Materials Science, multidisciplinary 6.5%)
Tissue Ablation: Applications and Perspectives. (Review paper)
H. Keum, E. Cevik, J. Kim, Y. M. Demirlenk, D. Atar, G. Saini, R. A. Sheth, A. R. Deipolyi, R. Oklu*
Adv. Mater. 36(32): 2310856 (2024) (IF: 27.4, Materials Science, multidisciplinary 2.4%)
Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models.
Demirlenk, Y. M., H. Albadawi, Z. Zhang, D. Atar, E. Cevik, H. Keum, J. Kim, S. Rehman, S. Gunduz, E. Graf, J. L. Mayer, P. R. Dos Santos and R. Oklu*
Sci. Transl. Med. 16(754): eadn7982 (2024) (IF: 15.8, Medicine, research & experimental 0.8%)
Catheter-Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation.
E. Cevik, H. Albadawi, Z. Zhang, Y. Demirlenk, D. Atar, C. Keum, J. Kim, E. Graf, S. Gunduz, S. Rehman, R. Oklu*
Adv. Mater. 36(29): 2402570 (2024) (IF: 27.4, Materials Science, multidisciplinary 2.4%)
Photonic control of ligand nanospacing in self-assembly regulates stem cell fate.
Lee, S., J. Yoo, G. Bae, R. Thangam, J. Heo, J. Y. Park, H. Choi, C. Kim, J. An, J. Kim, K. R. Mun, S. Shin, K. Y. Zhang, P. C. Zhao, Y. Kim, N. Y. Kang, S. B. Han, D. Kim, J. Yoon, M. S. Kang, J. Kim, L. T. Yang, S. Karamikamkar, J. Kim, Y. Z. Zhu, A. H. Najafabadi, G. S. Song, D. H. Kim, K. B. Lee, S. J. Oh, H. D. Jung, H. C. Song, W. Y. Jang, L. M. Bian, Z. Q. Chu, J. Yoon, J. S. Kim, Y. S. Zhang, Y. Kim, H. S. Jang, S. Kim and H. M. Kang*
Bioactive Materials 34: 164-180 (2024) (IF: 18.0, Materials Science, biomaterials 0.9%)
Gelatin methacryloyl and Laponite bioink for 3D bioprinted organotypic tumor modeling.
de Barros, N. R., A. Gomez, M. Ermis, N. Falcone, R. Haghniaz, P. Young, Y. Q. Gao, A. F. Aquino, S. Y. Li, S. Y. Niu, R. R. Chen, S. Y. Huang, Y. Z. Zhu, P. Eliahoo, A. R. Sun, D. Khorsandi, J. Kim, J. Kelber, A. Khademhosseini*, H. J. Kim* and B. B. Li*
Biofabrication 15(4):054005 (2023) (IF: 9.0, Engineering, biomedical 10.9%)
Skin-interfaced electronics: A promising and intelligent paradigm for personalized healthcare. (Review paper)
Zhu, Y.*, Li, J., Kim, J., Li, S., Zhao, Y., Bahari, J., Eliahoo, P., Li, G., Kawakita, S., Haghniaz, R., Gao, X., Falcone, N., Ermis, M., Kang, H., Liu, H., Kim, H., Tabish, T., Yu, H., Li, B., Akbari, M., Emaminejad, S., Khademhosseini, A*
Biomaterials 296:122075 (2023) (IF: 14.0, Materials science, biomaterials 3.3%)
Photoswitchable Microgels for Dynamic Macrophage Modulation.
Kim, Y., Thangam, R., Yoo, J., Heo, J., Park, J. Y., Kang, N., Lee, S., Yoon, J., Mun, K. R., Kang, M., Min, S., Kim, S. Y., Son, S., Kim, J., Hong, H., Bae, G., Kim, K., Lee, S., Yang, L., Lee, J. Y., Kim, J., Park, S., Kim, D.-H., Lee, K.-B., Jang, W. Y., Kim, B. H., Paulmurugan, R., Cho, S.-W., Song, H.-C., Kang, S. J., Sun, W., Zhu, Y., Lee, J., Kim, H.-J., Jang, H. S., Kim, J. S., Khademhosseini, A., Kim, Y., Kim, S., Kang, H.*
Adv. Mater. 34(49):2205498 (2022) (IF: 32.086, Materials Science, multidisciplinary 2.17%)
Systematic Screening and Therapeutic Evaluation of Glyconanoparticles with Differential Cancer Affinities for Targeted Cancer Therapy.
Whang, C.-H., Hong, J., Kim, D., Ryu, H., Jung, W., Son, Y., Keum, H., Kim, J., Shin, H., Moon, E., Noh, I., Lee, H.-S.*, Jon, S.*
Adv. Mater. 34(30):2203993 (2022) (IF: 32.086, Materials Science, multidisciplinary 2.17%)
Effective Combination Immunotherapy through Vessel Normalization Using a Cancer-Targeting Antiangiogenic Peptide–Antibody Hybrid.
Yu, B., Yoo, D., Kim, K.H., Kim, T.W., Park, S., Kim, Y., Son, Y., Kim, J., Noh, I., Whang, C.-H., Chung, J. and Jon, S.*
Adv. Therap. 5(4):2100151 (2022) (IF: 5.003)
A Bilirubin-derived Nanomedicine Attenuates the Pathological Cascade of Pulmonary Fibrosis.
H Keum, D Kim, J Kim, T W Kim, C Whang, S Jon*
Biomaterials 275:120986 (2021) (IF: 12.479, Engineering, biomedical 2.81%)
Biomimetic lipid Nanocomplexes incorporating STAT3-inhibiting peptides effectively infiltrate the lung barrier and ameliorate pulmonary fibrosis.
Keum, H., J. Kim, D. Yoo, T. W. Kim, C. Seo, D. Kim and S. Jon*
J Control Release 332: 160-170 (2021) (IF: 9.776, Pharmacology & Pharmacy 3.44%)
Gold nanorods with an ultrathin anti-biofouling siloxane layer for combinatorial anticancer therapy.
J. Kim, H. Keum, H. Kim, B. Yu, W. Jung, C. Whang, C. Seo, J. H. Park and S. Jon*
Journal of Drug Targeting 28(7-8):780-788 (2020) (IF: 3.380)
Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling.
Keum, H., T. W. Kim, Y. Kim, C. Seo, Y. Son, J. Kim, D. Kim, W. Jung, C. H. Whang and S. Jon*
J Control Release 325: 359-369 (2020) (IF: 7.727, Pharmacology & Pharmacy 3.51%)
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse.
Kim, Y., S. Kang, H. Shin, T. Kim, B. Yu, J. Kim, D. Yoo and S. Jon*
Angew Chem Int Ed Engl 132(34):14736-14746 (2020) (IF: 12.959, Chemistry, multidisciplinary 8.19%)
J. Kim† , J. Lee† , J. Lee, H. Keum, Y. Kim, Y. Kim, B. Yu, S. Y. Lee, J. Tanaka, S. Jon* and M. C. Choi*
Adv. Mater. (Front cover) 32(33): 2002902 (2020) (IF: 27.398, Materials Science, multidisciplinary 2.07%)
A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy.
Yu, B., D. Hwang, H. Jeon, H. Kim, Y. Lee, H. Keum, J. Kim, D. Y. Lee, Y. Kim, J. Chung and S. Jon*
Angew Chem Int Ed 131(7):2027-2032 (2019) (IF: 12.257, Chemistry, multidisciplinary 9.59%)
Nanoparticle-Assisted Transcutaneous Delivery of a Signal Transducer and Activator of Transcription 3-Inhibiting Peptide Ameliorates Psoriasis-like Skin Inflammation.
Kim, J. Y., J. Ahn, J. Kim, M. Choi, H. Jeon, K. Choe, D. Y. Lee, P. Kim and S. Jon*
ACS Nano 12(7):6904-6916 (2018) (IF: 13.709, Nanoscience & Nanothechnology 4.89%)
Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
Kang, S., S. Ahn, J. Lee, J. Y. Kim, M. Choi, V. Gujrati, H. Kim, J. Kim, E. C. Shin and S. Jon*
Journal of Controlled Release 256: 56-67 (2017) (IF: 7.786, Pharmacology & Pharmacy 3.7%)
Prevention of Bacterial Colonization on Catheters by a One-Step Coating Process Involving an Antibiofouling Polymer in Water.
Keum, H., J. Y. Kim, B. Yu, S. J. Yu, J. Kim, H. Jeon, D. Y. Lee, S. G. Im and S. Jon*
ACS Applied Materials & Interfaces 9(23):19736-19745 (2017) (IF: 7.054, Materials Science, multidisciplinary 7.82%)
J. Kim† , H. Kim† , J. H. Park* and S. Jon*
Nanotheranostics 1(2): 178-185 (2017)
Substituent Effects in BODIPY in Live Cell Imaging.
Mulay, S. V., T. Yudhistira, M. Choi, Y. Kim, J. Kim, Y. J. Jang, S. Jon and D. G. Churchill*
Chemistry-an Asian Journal 11(24): 3598-3605 (2016) (IF: 4.592)
Self-assembled nanoparticles comprising aptide-SN38 conjugates for use in targeted cancer therapy.
Kim, H., Y. Lee, S. Kang, M. Choi, S. Lee, S. Kim, V. Gujrati, J. Kim and S. Jon*
Nanotechnology 27(48) (2016) (IF: 3.573)
Photo-decomposable Organic Nanoparticles for Combined Tumor Optical Imaging and Multiple Phototherapies.
Miao, W. J., H. J. Kim, V. Gujrati, J. Y. Kim, H. Jon, Y. Lee, M. Choi, J. Kim, S. Lee, D. Y. Lee, S. Kang and S. Jon*
Theranostics 6(13): 2367-2379 (2016) (IF: 8.854, Medicine, research & experimental 6.85%)
Bioengineered yeast-derived vacuoles with enhanced tissue-penetrating ability for targeted cancer therapy.
Gujrati, V., M. Lee, Y. J. Ko, S. Lee, D. Kim, H. Kim, S. Kang, S. Lee, J. Kim, H. Jeon, S. C. Kim, Y. Jun and S. Jon*
Proceedings of the National Academy of Sciences of the United States of America 113(3): 710-715 (2016) (IF: 9.423, Multidisciplinary Sciences 5.56%)
Effect of PEG Pairing on the Efficiency of Cancer-Targeting Liposomes.
Saw, P. E., J. Park, E. Lee, S. Ahn, J. Lee, H. Kim, J. Kim, M. Choi, O. C. Farokhzad and S. Jon*
Theranostics 5(7):746-754 (2015) (IF: 8.022, Medicine, research & experimental 7.72%)
Preparation and therapeutic evaluation of paclitaxel-conjugated low-molecular-weight chitosan nanoparticles.
Kim, H., E. Lee, I. H. Lee, J. Lee, J. Kim, S. Kim, Y. Lee, D. Kim, M. Choi, Y. C. Kim and S. Jon*
Macromolecular Research 22(8):805-808 (2014) (IF: 1.682)
Page updated
Google Sites
Report abuse